| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cytosolic [4Fe-4S] assembly targeting complex | 1.44e-04 | 5 | 80 | 2 | GO:0097361 | |
| MousePheno | abnormal circulating phosphate level | 2.91e-05 | 260 | 66 | 8 | MP:0001565 | |
| MousePheno | abnormal phosphate level | 3.07e-05 | 262 | 66 | 8 | MP:0020885 | |
| Domain | HEAT | 1.77e-06 | 48 | 79 | 5 | PF02985 | |
| Domain | HEAT | 4.58e-06 | 58 | 79 | 5 | IPR000357 | |
| Domain | AAA | 6.88e-05 | 52 | 79 | 4 | PF00004 | |
| Domain | ATPase_AAA_core | 7.98e-05 | 54 | 79 | 4 | IPR003959 | |
| Domain | HEAT_REPEAT | 2.20e-04 | 70 | 79 | 4 | PS50077 | |
| Domain | E2F_CC-MB | 2.62e-04 | 6 | 79 | 2 | IPR032198 | |
| Domain | E2F_CC-MB | 2.62e-04 | 6 | 79 | 2 | PF16421 | |
| Domain | AAA+_ATPase | 3.62e-04 | 144 | 79 | 5 | IPR003593 | |
| Domain | AAA | 3.62e-04 | 144 | 79 | 5 | SM00382 | |
| Domain | AAA | 3.97e-04 | 34 | 79 | 3 | PS00674 | |
| Domain | E2F | 4.87e-04 | 8 | 79 | 2 | IPR015633 | |
| Domain | Adenylat/UMP-CMP_kin | 7.78e-04 | 10 | 79 | 2 | IPR000850 | |
| Domain | E2F_TDP | 9.48e-04 | 11 | 79 | 2 | PF02319 | |
| Domain | E2F_TDP | 9.48e-04 | 11 | 79 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 9.48e-04 | 11 | 79 | 2 | IPR003316 | |
| Domain | ARM-like | 9.93e-04 | 270 | 79 | 6 | IPR011989 | |
| Domain | MORN | 1.56e-03 | 14 | 79 | 2 | SM00698 | |
| Domain | MORN | 1.79e-03 | 15 | 79 | 2 | IPR003409 | |
| Domain | MORN | 1.79e-03 | 15 | 79 | 2 | PF02493 | |
| Domain | ConA-like_dom | 2.36e-03 | 219 | 79 | 5 | IPR013320 | |
| Domain | - | 2.50e-03 | 222 | 79 | 5 | 1.25.10.10 | |
| Domain | ARM-type_fold | 3.13e-03 | 339 | 79 | 6 | IPR016024 | |
| Domain | - | 3.19e-03 | 20 | 79 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 3.19e-03 | 20 | 79 | 2 | IPR001279 | |
| Domain | C2_dom | 5.17e-03 | 164 | 79 | 4 | IPR000008 | |
| Domain | Bromodomain_CS | 5.38e-03 | 26 | 79 | 2 | IPR018359 | |
| Domain | ATPase_AAA_CS | 6.66e-03 | 29 | 79 | 2 | IPR003960 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 3.29e-05 | 17 | 53 | 3 | M14449 | |
| Pathway | BIOCARTA_ETS_PATHWAY | 3.29e-05 | 17 | 53 | 3 | MM1435 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12110166 | ||
| Pubmed | PI3Kδ activates E2F1 synthesis in response to mRNA translation stress. | 5.63e-06 | 2 | 83 | 2 | 29235459 | |
| Pubmed | Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value. | 5.63e-06 | 2 | 83 | 2 | 26856934 | |
| Pubmed | Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas. | 5.63e-06 | 2 | 83 | 2 | 11759817 | |
| Pubmed | Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation. | 5.63e-06 | 2 | 83 | 2 | 11005809 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 10779331 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24038143 | ||
| Pubmed | E2F transcription factors associated with up-regulated genes in glioblastoma. | 5.63e-06 | 2 | 83 | 2 | 27983535 | |
| Pubmed | DIMT1 ACAD11 ATAD5 BRPF1 PEX6 MMS19 CSMD1 PADI2 ZMYM3 WWC1 ARHGAP33 FAM83H | 1.34e-05 | 1116 | 83 | 12 | 31753913 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | PIK3R4 NCAPD3 DIMT1 ACAD11 ATAD5 TAF1B UTP20 HNRNPUL1 DDOST DNMT1 | 1.34e-05 | 759 | 83 | 10 | 35915203 |
| Pubmed | Repression of androgen receptor transcription through the E2F1/DNMT1 axis. | 1.69e-05 | 3 | 83 | 2 | 21966451 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 24502362 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17908821 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21789246 | ||
| Pubmed | The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors. | 1.69e-05 | 3 | 83 | 2 | 30967472 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30887657 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 22688350 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31194977 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 39014186 | ||
| Pubmed | E2F transcriptional activation requires TRRAP and GCN5 cofactors. | 3.37e-05 | 4 | 83 | 2 | 11418595 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 16758952 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24109597 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 12799438 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10888886 | ||
| Pubmed | Myc requires distinct E2F activities to induce S phase and apoptosis. | 3.37e-05 | 4 | 83 | 2 | 11511364 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 20133863 | ||
| Pubmed | The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis. | 3.37e-05 | 4 | 83 | 2 | 26369285 | |
| Pubmed | Ectopic expression of necdin induces differentiation of mouse neuroblastoma cells. | 3.37e-05 | 4 | 83 | 2 | 12198120 | |
| Pubmed | Intestinal hyperplasia induced by simian virus 40 large tumor antigen requires E2F2. | 3.37e-05 | 4 | 83 | 2 | 17855529 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 4.56e-05 | 877 | 83 | 10 | 20211142 | |
| Pubmed | A role for E2F6 in the restriction of male-germ-cell-specific gene expression. | 5.60e-05 | 5 | 83 | 2 | 15936277 | |
| Pubmed | Transcriptional regulation of fibrillin-2 gene by E2F family members in chondrocyte differentiation. | 5.60e-05 | 5 | 83 | 2 | 19142862 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 12401786 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 11004506 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 18542057 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 29059406 | ||
| Pubmed | NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1. | 5.60e-05 | 5 | 83 | 2 | 35085770 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 10215863 | ||
| Pubmed | A role for E2F activities in determining the fate of Myc-induced lymphomagenesis. | 5.60e-05 | 5 | 83 | 2 | 19749980 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 10869426 | ||
| Pubmed | PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. | 8.39e-05 | 6 | 83 | 2 | 20622854 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 21454377 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 9426200 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 9694791 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 8816797 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 22508987 | ||
| Pubmed | Expression of the E2F family of transcription factors during murine development. | 8.39e-05 | 6 | 83 | 2 | 10853823 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PIK3R4 DIMT1 MYH14 TAF1B DOCK10 UTP20 MMS19 HNRNPUL1 DDOST ZMYM3 FAM83H DNMT1 | 8.64e-05 | 1353 | 83 | 12 | 29467282 |
| Pubmed | Stage-Specific Demethylation in Primordial Germ Cells Safeguards against Precocious Differentiation. | 1.17e-04 | 7 | 83 | 2 | 27618282 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 8832394 | ||
| Pubmed | Patterns of cell signaling pathway activation that characterize mammary development. | 1.17e-04 | 7 | 83 | 2 | 18550711 | |
| Pubmed | Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. | 1.17e-04 | 7 | 83 | 2 | 9343408 | |
| Pubmed | Aberrant regulation of survivin by the RB/E2F family of proteins. | 1.17e-04 | 7 | 83 | 2 | 15271987 | |
| Pubmed | E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. | 1.17e-04 | 7 | 83 | 2 | 8657117 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 12789259 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 12096339 | ||
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 17612494 | ||
| Pubmed | E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. | 1.17e-04 | 7 | 83 | 2 | 7892279 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 9376316 | ||
| Pubmed | E2F-6, a member of the E2F family that can behave as a transcriptional repressor. | 1.17e-04 | 7 | 83 | 2 | 9501179 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.26e-04 | 202 | 83 | 5 | 33005030 | |
| Pubmed | Expression patterns of the E2F family of transcription factors during murine epithelial development. | 1.56e-04 | 8 | 83 | 2 | 9149906 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 15706352 | ||
| Pubmed | E2F-4, a new member of the E2F transcription factor family, interacts with p107. | 1.56e-04 | 8 | 83 | 2 | 7958924 | |
| Pubmed | The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification. | 1.56e-04 | 8 | 83 | 2 | 15448153 | |
| Pubmed | Canonical and atypical E2Fs regulate the mammalian endocycle. | 1.56e-04 | 8 | 83 | 2 | 23064266 | |
| Pubmed | EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. | 1.56e-04 | 8 | 83 | 2 | 19457859 | |
| Pubmed | Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F. | 1.56e-04 | 8 | 83 | 2 | 17062573 | |
| Pubmed | The human adenylate kinase 9 is a nucleoside mono- and diphosphate kinase. | 1.56e-04 | 8 | 83 | 2 | 23416111 | |
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 16061792 | ||
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 16360038 | ||
| Pubmed | 1.56e-04 | 8 | 83 | 2 | 20855524 | ||
| Pubmed | An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. | 2.00e-04 | 9 | 83 | 2 | 12007404 | |
| Pubmed | Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts. | 2.00e-04 | 9 | 83 | 2 | 17923680 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 9244350 | ||
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 12411495 | ||
| Pubmed | E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. | 2.50e-04 | 10 | 83 | 2 | 11799067 | |
| Pubmed | MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells. | 2.50e-04 | 10 | 83 | 2 | 32032549 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 23585563 | ||
| Pubmed | Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. | 2.50e-04 | 10 | 83 | 2 | 7797074 | |
| Pubmed | Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. | 2.50e-04 | 10 | 83 | 2 | 20392944 | |
| Pubmed | Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. | 2.50e-04 | 10 | 83 | 2 | 15664192 | |
| Pubmed | 2.50e-04 | 10 | 83 | 2 | 17210791 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 MAP1S PIK3CD MYOM3 TIGD3 PEX6 LRRK1 ATG2A ARHGAP33 FAM83H | 3.00e-04 | 1105 | 83 | 10 | 35748872 |
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 3.05e-04 | 11 | 83 | 2 | 16579977 | |
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 10766737 | ||
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 15735762 | ||
| Pubmed | Specific regulation of E2F family members by cyclin-dependent kinases. | 3.05e-04 | 11 | 83 | 2 | 9199321 | |
| Pubmed | Target gene specificity of E2F and pocket protein family members in living cells. | 3.66e-04 | 12 | 83 | 2 | 10913163 | |
| Pubmed | Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor. | 3.66e-04 | 12 | 83 | 2 | 12748276 | |
| Pubmed | 3.85e-04 | 257 | 83 | 5 | 30945288 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 4.20e-04 | 262 | 83 | 5 | 36880596 | |
| Pubmed | 4.31e-04 | 13 | 83 | 2 | 22993228 | ||
| Pubmed | 5.03e-04 | 14 | 83 | 2 | 9190208 | ||
| Pubmed | 5.03e-04 | 14 | 83 | 2 | 25150253 | ||
| Pubmed | STRA8-RB interaction is required for timely entry of meiosis in mouse female germ cells. | 5.03e-04 | 14 | 83 | 2 | 37880249 | |
| Pubmed | A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. | 5.03e-04 | 14 | 83 | 2 | 9253601 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.27e-04 | 774 | 83 | 8 | 15302935 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 5.79e-04 | 15 | 83 | 2 | 17255939 | |
| Pubmed | MMS19 links cytoplasmic iron-sulfur cluster assembly to DNA metabolism. | 5.79e-04 | 15 | 83 | 2 | 22678361 | |
| GeneFamily | AAA ATPases | 1.87e-05 | 53 | 54 | 4 | 413 | |
| GeneFamily | E2F transcription factors | 2.42e-04 | 8 | 54 | 2 | 982 | |
| GeneFamily | Adenylate kinases | 3.11e-04 | 9 | 54 | 2 | 356 | |
| GeneFamily | Synaptotagmins | 1.16e-03 | 17 | 54 | 2 | 765 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 5.25e-08 | 183 | 83 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.07e-06 | 179 | 83 | 6 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-06 | 179 | 83 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-06 | 183 | 83 | 6 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.21e-06 | 183 | 83 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.29e-06 | 185 | 83 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 190 | 83 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 167 | 83 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-05 | 173 | 83 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.86e-05 | 174 | 83 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-05 | 175 | 83 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 178 | 83 | 5 | 674ee5095b98929c29e4f6bd56029a336cc4a38c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.13e-05 | 179 | 83 | 5 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-05 | 179 | 83 | 5 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-05 | 180 | 83 | 5 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.19e-05 | 180 | 83 | 5 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 182 | 83 | 5 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-05 | 182 | 83 | 5 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-05 | 184 | 83 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-05 | 185 | 83 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 2.56e-05 | 186 | 83 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-05 | 187 | 83 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.62e-05 | 187 | 83 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.69e-05 | 188 | 83 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.69e-05 | 188 | 83 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.69e-05 | 188 | 83 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-05 | 189 | 83 | 5 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-05 | 189 | 83 | 5 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.76e-05 | 189 | 83 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.90e-05 | 191 | 83 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.98e-05 | 192 | 83 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.05e-05 | 193 | 83 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.13e-05 | 194 | 83 | 5 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-05 | 195 | 83 | 5 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 197 | 83 | 5 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-05 | 198 | 83 | 5 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.45e-05 | 198 | 83 | 5 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 3.53e-05 | 199 | 83 | 5 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 3.62e-05 | 200 | 83 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 3.62e-05 | 200 | 83 | 5 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 200 | 83 | 5 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c10-IFNG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.08e-05 | 126 | 83 | 4 | d19382597ce5c6546731ac1fd33c7dcb7916b2ea | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 134 | 83 | 4 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 144 | 83 | 4 | f501e11b1d051ca67124137017a79a2d5bb6ae87 | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.87e-04 | 152 | 83 | 4 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.97e-04 | 154 | 83 | 4 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-04 | 157 | 83 | 4 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.12e-04 | 157 | 83 | 4 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 159 | 83 | 4 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 159 | 83 | 4 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 159 | 83 | 4 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 2.22e-04 | 159 | 83 | 4 | 595643e9433265308e5aab7f906229025701cf6a | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 160 | 83 | 4 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 160 | 83 | 4 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 161 | 83 | 4 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 162 | 83 | 4 | ee6f05620f4f4ebbebd5b098afc7c20876e3d21f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 162 | 83 | 4 | 9e72d468fcdd0d27b517a9e36efb35d4617a88f9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.44e-04 | 163 | 83 | 4 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-04 | 165 | 83 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 165 | 83 | 4 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 166 | 83 | 4 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-04 | 167 | 83 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.68e-04 | 167 | 83 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 2.68e-04 | 167 | 83 | 4 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 169 | 83 | 4 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-04 | 169 | 83 | 4 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.87e-04 | 170 | 83 | 4 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-04 | 170 | 83 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.87e-04 | 170 | 83 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 170 | 83 | 4 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.00e-04 | 172 | 83 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 172 | 83 | 4 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 172 | 83 | 4 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.00e-04 | 172 | 83 | 4 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-04 | 172 | 83 | 4 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 173 | 83 | 4 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 173 | 83 | 4 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 173 | 83 | 4 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 174 | 83 | 4 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-04 | 174 | 83 | 4 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-04 | 175 | 83 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.20e-04 | 175 | 83 | 4 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.27e-04 | 176 | 83 | 4 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-04 | 176 | 83 | 4 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 177 | 83 | 4 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.34e-04 | 177 | 83 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 177 | 83 | 4 | 2433924dcb085ebbe2545d476ebd7ee68e6092fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-4_RORB_FOLH1B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 178 | 83 | 4 | 22955b82917206aeed49dc0ac4630ccd9e51c4a5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 178 | 83 | 4 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 6.39e-06 | 196 | 81 | 7 | 4582_UP | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 6.61e-06 | 197 | 81 | 7 | 1543_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.06e-06 | 199 | 81 | 7 | 2787_UP | |
| Drug | LY294002; Up 200; 10uM; PC3; HT_HG-U133A | 6.20e-05 | 191 | 81 | 6 | 5970_UP | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 6.96e-05 | 195 | 81 | 6 | 2790_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 3682_UP | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 4590_DN | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 6737_DN | |
| Drug | aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 1204_UP | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; PC3; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 4097_DN | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; HL60; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 1855_DN | |
| Drug | Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 1680_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 1522_UP | |
| Drug | Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; HL60; HG-U133A | 7.57e-05 | 198 | 81 | 6 | 1426_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 6019_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 81 | 6 | 6458_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.78e-05 | 199 | 81 | 6 | 6624_DN | |
| Disease | cortical surface area measurement | THSD4 PITPNM2 NCAPD3 SEMA3D ACAD11 PMPCA PIK3CD ATAD2B ETS1 DOCK10 SYT4 ADGRV1 SVEP1 SLC39A8 WWC1 | 3.38e-06 | 1345 | 81 | 15 | EFO_0010736 |
| Disease | 2-stearoylglycerophosphocholine measurement | 7.44e-06 | 2 | 81 | 2 | EFO_0021098 | |
| Disease | sexual dimorphism measurement | PITPNM2 HROB CITED4 PMPCA ATAD5 CIAO3 FER1L4 WBP1L ATAD2B E2F1 SLC39A8 AKAP7 | 4.72e-05 | 1106 | 81 | 12 | EFO_0021796 |
| Disease | brain measurement, hippocampal volume | 1.11e-04 | 6 | 81 | 2 | EFO_0004464, EFO_0005035 | |
| Disease | glioblastoma (is_marker_for) | 2.43e-04 | 44 | 81 | 3 | DOID:3068 (is_marker_for) | |
| Disease | pulse pressure measurement | PIK3R4 THSD4 MALRD1 WBP1L ATAD2B UGT2B7 DDI2 SYT4 SNX19 SVEP1 LDB2 DNMT1 | 4.02e-04 | 1392 | 81 | 12 | EFO_0005763 |
| Disease | CCL2 measurement | 4.09e-04 | 126 | 81 | 4 | EFO_0004749 | |
| Disease | monocyte percentage of leukocytes | 8.95e-04 | 731 | 81 | 8 | EFO_0007989 | |
| Disease | Nonsyndromic Deafness | 1.46e-03 | 81 | 81 | 3 | C3711374 | |
| Disease | ICAM-1 measurement | 1.98e-03 | 24 | 81 | 2 | EFO_0004520 | |
| Disease | Lynch syndrome (is_implicated_in) | 1.98e-03 | 24 | 81 | 2 | DOID:3883 (is_implicated_in) | |
| Disease | colorectal health | 2.31e-03 | 201 | 81 | 4 | EFO_0008460 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.32e-03 | 26 | 81 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 2.32e-03 | 26 | 81 | 2 | EFO_0007870 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.50e-03 | 27 | 81 | 2 | DOID:8552 (is_marker_for) | |
| Disease | hearing impairment | 2.51e-03 | 98 | 81 | 3 | C1384666 | |
| Disease | mean arterial pressure | 2.53e-03 | 499 | 81 | 6 | EFO_0006340 | |
| Disease | lumbar disc degeneration | 2.69e-03 | 28 | 81 | 2 | EFO_0004994 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGCTFHLLTPEEEFS | 281 | Q60I27 | |
| DGCFEEIKFSTPSLL | 1346 | Q96QE3 | |
| LVGEDAVFSCSLFPE | 31 | Q6UXE8 | |
| GDTLTFECPAAFELV | 546 | Q96PZ7 | |
| GATSDPLELFLVDEC | 806 | P26358 | |
| FEACFPSILVPDAEE | 656 | Q6ULP2 | |
| CFPFSRDEGKISELE | 6 | O43687 | |
| DDPFGVFILDPECLE | 1236 | Q8WXG9 | |
| RCLDSVLGEFAFPDE | 281 | Q8TF64 | |
| TLDSDEFCILDAPGL | 1356 | Q2TAZ0 | |
| LIAEETGKCFFAPDV | 451 | Q709F0 | |
| FVDSVPEFCLPETEL | 76 | Q9NV88 | |
| PTRLCDLFITGEDFD | 326 | Q6NTE8 | |
| SCPVIFILDEFDLFA | 151 | O43929 | |
| GFPDLEVEFISCLDL | 341 | P0C881 | |
| GFPDLEVEFISCLDL | 341 | B2RC85 | |
| NLEGPEIFFEDELVC | 136 | O94952 | |
| TSEIDFIFCDLPPLL | 171 | Q8NGQ5 | |
| PADVCGPLFEEELAF | 126 | Q96PR1 | |
| GLCEFLEYVAESLEP | 206 | Q66K74 | |
| AFFSTLCPEGDIDIL | 601 | Q4ZG55 | |
| EFEDPELSATLCELS | 566 | Q8IX03 | |
| EFPAFLSESLEVLCL | 541 | Q38SD2 | |
| SLGPFVEELFEVTSC | 206 | Q96T76 | |
| EASTDSFEGIPVLEC | 1271 | Q9ULI0 | |
| LAPCEDFLLFGVLFE | 421 | A9Z1Z3 | |
| DDATLTLSFCLEDGP | 61 | O43679 | |
| RSELEDFPVLGIDCE | 96 | Q9NVH0 | |
| DCFLELAPDFVGDIL | 111 | P14921 | |
| TFLDFGLDLQPCIDL | 526 | Q7Z406 | |
| APCIIFFDELDSLAP | 796 | Q13608 | |
| DGLLSELPEDFFCGT | 631 | Q8N3J3 | |
| AELLFFVEGLCFPDE | 246 | Q9Y2J8 | |
| DFEITDLFLFGCPLG | 716 | Q9BZ72 | |
| DPLRELGSECGIEFD | 136 | P39656 | |
| AFFEEVCLDLESSPS | 391 | C9JSJ3 | |
| DIFIALDDISFTPEC | 1876 | Q5VYJ5 | |
| VESCAFDLTSPDDVL | 181 | Q969V1 | |
| CLEGLRGLDFDPLTF | 731 | O14559 | |
| FGEFESPACELLDQV | 211 | P0CF75 | |
| IRDLFDCDFGDLTPL | 421 | Q01094 | |
| LDESEGVCDLFDVPV | 396 | Q16254 | |
| PSPEVSDFFSILDVC | 1361 | Q96BY6 | |
| LETVSEDFTCLPLFL | 171 | Q8N0S6 | |
| DLDPKAVTCDELFGI | 2156 | Q9UFH2 | |
| AFLLIEDLTGSCFEP | 141 | A5D6W6 | |
| GCEADITPEDLFNIF | 191 | Q8TBM8 | |
| DDFGLVKLFDFPCTE | 1901 | Q6ZMW3 | |
| IEGDFLPCSFSILEE | 301 | Q5TDH0 | |
| FLATEGAPDFLCPEE | 46 | Q6ZRV2 | |
| TIVEFECRGLEPVDF | 96 | Q9NWV4 | |
| VGDVLKTDLPFFDTC | 111 | Q9UNQ2 | |
| TLPDVGDFLDEVLFI | 566 | Q9BUJ2 | |
| PLLDLECTDTYFVGL | 181 | P0C604 | |
| ELFVFDIPCEGLEDI | 356 | Q9H2B2 | |
| DIPCEGLEDISVEFL | 361 | Q9H2B2 | |
| LGEFEQFCPVSLAES | 1636 | Q5TCS8 | |
| SCSFLEEDFIPFAVL | 326 | Q10713 | |
| LICGLFVESEGVDFE | 2386 | O75691 | |
| ESLEPPSEFGDLQFC | 271 | Q9BQS2 | |
| ALDTLVICLEDFDPG | 126 | O75602 | |
| TFLDLPRFPDITEDC | 286 | Q53T94 | |
| AIPENGCIEELAFTF | 1851 | Q4LDE5 | |
| IFGIEFNSTFLECIP | 601 | O95025 | |
| CSLVSTPEEILFEDA | 236 | Q7Z7C7 | |
| CFANTVFLEPIDSIE | 361 | P55201 | |
| LTDLDDFIGPSQECI | 11 | Q9H6Q4 | |
| ELPELFLGQSEFDCF | 156 | Q96RK1 | |
| CFADGILPLDLDASE | 1126 | P42695 | |
| CVIAELFTEGVPLFD | 246 | Q99570 | |
| DFSPEDVFGCAELPL | 166 | Q6B0B8 | |
| VLSALELLDFSFPDC | 576 | O00329 | |
| FLCEDSELESPLSEL | 366 | Q92543 | |
| LLPAFVFIGLEQDDC | 61 | P30408 | |
| LCEEFPHELGDFVIL | 341 | Q9C0K1 | |
| LLDITEEDCFSLFPL | 191 | Q6PF06 | |
| DVIFADAIFPCSELL | 146 | P16662 | |
| TFEVLDPSECSFLEK | 886 | Q6ZMP0 | |
| TLIDDALDGPLDFCD | 271 | Q9NX94 | |
| DINPSVDFLFDCGLV | 1006 | Q14202 | |
| VDFLFDCGLVGPEDV | 1011 | Q14202 | |
| ESVCFEVLGFDILLD | 326 | Q6ZT98 | |
| AAPELVFEPTTCEAF | 101 | Q9NQA5 | |
| IIPEFVCALDASDEF | 516 | Q96M32 | |
| EPFSLSCLFSEDVLD | 286 | Q5VTT5 |